The Covid-19 infection: An opportunity to develop systematic vitamin D supplementation in psychiatry
Encephale. 2021 Mar 14;S0013-7006(21)00057-9. doi: 10.1016/j.encep.2021.02.002
G Fond 1, M Masson 2, R Richieri 3, T Korchia 3, D Etchecopar-Etchart 3, P-L Sunhary de Verville 3, C Lançon 3, L Boyer 3
Study on this page recommends 50,000 IU monthly, which has been found to be not nearly enough
26 health factors increase the risk of COVID-19 – all are associated with low vitamin D
Reduce COVID-19 risks with 50,000 IU Vitamin D doses - weekly, not monthly
- Many COVID-19 risks are associated with low vitamin D (7 studies) – Systematic Review Jan 2021
- Health Problems and D on the left of every Vitamin D Life page
- 27 health problems proven by RCT to be fought by 50,000 IU every 2 weeks
- 18 health problems proven by RCT to be fought by 50,000 IU every week
- Many drugs increase ACE2 and COVID-19 (176 page review) - Dec 2020
COVID-19 treated by Vitamin D - studies, reports, videos
As of May 1 the page had: 34 trials, 5 trial results, 17 meta-analyses and reviews, 56 observations, 34 recommendations, 53 associations, 86 speculations, 44 videos see related: Governments, HealthProblems, Hospitals, Dark Skins, 26 risk factors are ALL associated with low Vit D, Recent Virus pages Fight COVID-19 with 50K Vit D weekly Vaccine problems
Schizophrenia increased risk of COVID-19 by 1.3 X (ref #1 by this stud:)
Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study
Download the PDF from Vitamin D Life
Download the PDF from Vitamin D Life
Psychiatric patients are at risk of hypovitaminosis D and Covid-19-related mortality. In addition to the mental health benefits, vitamin D supplementation may be potentially effective in preventing severe forms of Covid-19 infections. Vitamin D supplementation is not necessary and is not reimbursed in France for this indication. A monthly supplementation of 50,000 IU may be sufficient in most cases. Double the dose is recommended for obese patients. The risk of renal lithiasis is not increased at these doses, even when supplemented in a patient without vitamin D deficiency. The Covid-19 crisis is an opportunity to disseminate vitamin D supplementation in psychiatric patients, as it has been shown to be effective in other respiratory diseases such as mild upper respiratory tract infections and influenza.